Fusion Pharmaceuticals Inc
FUSN
Market Cap$1.83B
Close$
$-0.86
104% downside
Current Fair Value
104% downsideOvervalued by 104% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.83 Billion |
|---|---|
| Enterprise Value | $1.68 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.43 |
| Beta | 0.56 |
| Outstanding Shares | 85,059,965 |
| Avg 30 Day Volume | 636,159 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -17.51 |
|---|---|
| PEG | -45.36 |
| Price to Sales | - |
| Price to Book Ratio | 10.76 |
| Enterprise Value to Revenue | 823.66 |
| Enterprise Value to EBIT | -15.24 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
ESG Score
No data